Aberrant overexpression of vascular endothelial growth factor in pancreatic ductal adenocarcinoma is associated with aggressive clinical behavior
Naomi Y Jiang1, Bruce A Woda2, Liping Zhang2, Suyang Hao2, Karen A Dresser2, Di Lu21Massachusetts Institute of Technology, Worcester, MA, USA; 2Department of Pathology, University of Massachusetts Medical Center, Worcester, MA, USAAbstract: Pancreatic adenocarcinoma is a leading cause of cancer-rela...
Saved in:
Main Authors: | Naomi Y Jiang (Author), Bruce A Woda (Author), Liping Zhang (Author), et al (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2010-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Surgical Treatment of Pancreatic Ductal Adenocarcinoma
Published: (2021) -
Nimbolide Inhibits SOD2 to Control Pancreatic Ductal Adenocarcinoma Growth and Metastasis
by: Tugba Mehmetoglu-Gurbuz, et al.
Published: (2023) -
Targeting hyaluronan for the treatment of pancreatic ductal adenocarcinoma
by: Norihiro Sato, et al.
Published: (2016) -
Therapeutic Targeting of Autophagy in Pancreatic Ductal Adenocarcinoma
by: Alexander G. Raufi, et al.
Published: (2021) -
Drug Repurposing Opportunities in Pancreatic Ductal Adenocarcinoma
by: Rita Rebelo, et al.
Published: (2021)